GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hua Medicine (OTCPK:HUMDF) » Definitions » Net Margin %

HUMDF (Hua Medicine) Net Margin % : -138.56% (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Hua Medicine Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Hua Medicine's Net Income for the six months ended in Jun. 2024 was $-19.61 Mil. Hua Medicine's Revenue for the six months ended in Jun. 2024 was $14.15 Mil. Therefore, Hua Medicine's net margin for the quarter that ended in Jun. 2024 was -138.56%.

The historical rank and industry rank for Hua Medicine's Net Margin % or its related term are showing as below:

HUMDF' s Net Margin % Range Over the Past 10 Years
Min: -1156.36   Med: -716.05   Max: -243.32
Current: -243.32


HUMDF's Net Margin % is ranked worse than
92.36% of 995 companies
in the Drug Manufacturers industry
Industry Median: 3.96 vs HUMDF: -243.32

Hua Medicine Net Margin % Historical Data

The historical data trend for Hua Medicine's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hua Medicine Net Margin % Chart

Hua Medicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial - - - -1,156.50 -275.74

Hua Medicine Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -561.97 -128.10 -1,930.15 -138.56

Competitive Comparison of Hua Medicine's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Hua Medicine's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hua Medicine's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hua Medicine's Net Margin % distribution charts can be found below:

* The bar in red indicates where Hua Medicine's Net Margin % falls into.



Hua Medicine Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Hua Medicine's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-29.584/10.729
=-275.74 %

Hua Medicine's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin=Net Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-19.607/14.151
=-138.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hua Medicine  (OTCPK:HUMDF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Hua Medicine Net Margin % Related Terms

Thank you for viewing the detailed overview of Hua Medicine's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hua Medicine Business Description

Traded in Other Exchanges
Address
Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203
Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC.

Hua Medicine Headlines